ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Obituaries

Obituary: Kimiyuki Shibuya

by Linda Wang
May 2, 2020 | APPEARED IN VOLUME 98, ISSUE 17

 

Kimiyuki Shibuya, 64, died on Feb. 17 in Tokyo.

“Dr. Shibuya established the manufacturing production process of our two pharmaceuticals, ripasudil for the treatment of glaucoma and pemafibrate, an antihyperlipidemic drug. He discovered the selective ACAT-1 inhibitor K-604, an antiarteriosclerotic agent.”—Tadaaki Ohgiya, friend and colleague

Most recent title: Laboratory manager, Kowa

Education: BS, chemistry, 1979; MS, chemistry, 1981; and PhD, chemistry, 1996, Tohoku University

Survivors: Sister, Kayoko Shibuya

To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment